Cambridge Epigenetix

Reagents and informatics solution that enables highly accurate genetic and epigenetic sequencing.

  • CEO: Gail Marcus
  • Location: Cambridge, England
  • Third Point Partner: Heath Terry
Go to site

Developer of epigenetic tools designed to reduce several routines and important diagnostic screening tests to a simple blood draw. The company's tools are used in the development of TrueMethyl kit, a rapid method for parallel genome-wide detection of cytosine methylation and hydroxy-methylation, and can be used with a variety of common platforms, including next-generation sequencing systems, methylation arrays, and targeted assays, enabling physicians to unleash the potential of precision medicine.